Question

A 22-year-old male presents with progressive tremors, slurred speech, and personality changes over the past few months. On examination, he has mild hepatomegaly, dysarthria, and a brownish ring around the cornea visible on slit-lamp examination (Kayser–Fleischer ring). Laboratory evaluation shows mildly elevated liver enzymes. Which of the following is the definitive diagnostic test for Wilson’s disease?

• A. Hepatic copper content
• B. Serum copper
• C. Urine copper
• D. Serum ceruloplasmin

Hint:

Wilson's Disease Testing Hierarchy:
Best Initial Screening Tests: Low Serum Ceruloplasmin and High 24-hour Urine Copper.
Best Physical Exam Finding: Kayser-Fleischer rings on slit-lamp exam.
Definitive Gold Standard Test: Quantitative Hepatic Copper $> 250$ mcg/g dry weight on biopsy.

Answer 1

The Correct Option is A

Concept:
A young adult male presents with a classic neuro-hepatic symptom complex: progressive neurological decline (tremors, severe dysarthria, personality changes), mild hepatic inflammation, and the pathognomonic ophthalmologic finding of a Kayser-Fleischer ring.
The clinical presentation is undeniably Wilson's disease. The question specifically asks for the "definitive" diagnostic test, distinguishing the ultimate gold standard from initial screening modalities.
Explanation:
• Wilson’s disease (hepatolenticular degeneration) is a rare autosomal recessive genetic disorder caused by deleterious mutations in the ATP7B gene, which encodes a hepatic copper-transporting ATPase.

• This genetic defect results in the profound failure of the liver to excrete excess systemic copper into the bile and its failure to properly incorporate copper into the transport protein ceruloplasmin.

• Consequently, toxic, unbound free copper progressively accumulates first in the liver, leading to hepatitis and eventual cirrhosis, and later prominently deposits in the basal ganglia of the brain and the Descemet's membrane of the cornea (forming the classic Kayser-Fleischer rings).

• For the initial clinical evaluation and screening, serum ceruloplasmin (Option D), which is typically decreased, and a 24-hour urine copper excretion test (Option C), which is markedly elevated, are excellent and standard first-line investigations.

• However, these serum and urine tests can occasionally yield false positives or false negatives, and therefore they do not constitute the absolute definitive proof of the disease.

• The ultimate, undisputed "gold standard" and definitive diagnostic test for confirming Wilson's disease is performing a liver biopsy to quantitatively measure the hepatic copper content (Option A).

• A quantitative hepatic copper concentration that is vastly elevated (typically finding $> 250$ $\mu$g of copper per gram of dry liver tissue) provides the definitive, conclusive diagnosis of the disorder.

• Total serum copper (Option B) is paradoxically usually low or entirely normal in these patients due to the marked lack of circulating ceruloplasmin (which normally carries 90% of serum copper), even though the tiny fraction of "free" serum copper is dangerously elevated.
Final Answer:
The quantitative measurement of hepatic copper content via a liver biopsy is the definitive gold standard diagnostic test for Wilson's disease.